Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KALEIDO BIOSCIENCES, INC.

(KLDO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société KALEIDO BIOSCIENCES, INC.
11/15Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ..
GL
11/10Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
GL
11/01KALEIDO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition ..
AQ
11/01Press Release issued by Kaleido Biosciences, Inc., dated November 1, 2021, furnished he..
PU
11/01Kaleido Biosciences Reports Third Quarter 2021 Financial Results
AQ
10/12KALEIDO BIOSCIENCES : to Participate in the Jefferies Virtual Next Generation IBD Therapeu..
AQ
10/05KALEIDO BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/05KALEIDO BIOSCIENCES : Announces New Clinical and Preclinical Data Supporting Advancement o..
AQ
09/29Kaleido Biosciences to Host Virtual R&D Presentation to Discuss Clinical Data and Pipel..
GL
09/03KALEIDO BIOSCIENCES, INC. : Other Events (form 8-K)
AQ
09/02Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Hea..
GL
08/11KALEIDO BIOSCIENCES : Press Release issued by Kaleido Biosciences, Inc., dated August 11, ..
PU
08/11KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/11Kaleido Biosciences Reports Second Quarter 2021 Financial Results
GL
08/10KALEIDO BIOSCIENCES : and the COPD Foundation Announce a Strategic Collaboration to Advanc..
AQ
08/09KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
AQ
08/09KALEIDO BIOSCIENCES : Announces New Chairperson Appointment to its Board of Directors
AQ
08/06KALEIDO BIOSCIENCES : to Participate in the 41st Annual Canaccord Genuity Growth Conferenc..
AQ
07/02KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/17KALEIDO BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Other Eve..
AQ
06/10Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
GL
05/04KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/04Kaleido Biosciences Reports First Quarter 2021 Financial Results
GL
04/21KALEIDO BIOSCIENCES : Announces Collaboration with Robert Jenq, M.D., to Explore Potential..
AQ
04/20Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
GL
04/15Kaleido Biosciences to Participate in Jefferies Microbiome-Based Therapeutics Summit
GL
03/25KALEIDO BIOSCIENCES : Reports Positive Results from Non-IND Study
AQ
03/24KALEIDO BIOSCIENCES, INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
AQ
03/24Kaleido Biosciences Reports Positive Results from Non-IND Study Demonstrating a Reducti..
GL
03/03Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
GL
03/03KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
03/02KALEIDO BIOSCIENCES : to Present at Chardan's 3rd Annual Microbiome Medicines Summit
AQ
03/01Kaleido Biosciences to Present at Chardan's 3rd Annual Microbiome Medicines Summit
GL
02/11Kaleido Biosciences Announces the Exercise of the Underwriters' Option to Purchase Addi..
GL
02/08KALEIDO BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events (form..
AQ
02/03Kaleido Biosciences Announces Pricing of Public Offering of Common Stock
GL
02/03Kaleido Biosciences Announces Proposed Public Offering of Common Stock
GL
01/25KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
AQ
01/20Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbio..
GL
01/20KALEIDO BIOSCIENCES : Other Events, Financial Statements and Exhibits (form 8-K/A)
AQ
01/19KALEIDO BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/14KALEIDO BIOSCIENCES, INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
AQ
01/14Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in ..
GL
01/05KALEIDO BIOSCIENCES : to Present at the 39th Annual J.P. Morgan Healthcare Conference
AQ
01/04Kaleido Biosciences Announces Completion of Enrollment of 350 Subjects in Controlled St..
GL
2020KALEIDO BIOSCIENCES : to Present at the Piper Sandler 32nd Annual Virtual Healthcare Confe..
AQ
2020Kaleido Biosciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conf..
GL
2020KALEIDO BIOSCIENCES : Reports Third Quarter 2020 Financial Results and Provides Corporate ..
AQ
2020Kaleido Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporat..
GL
2020KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2020KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020KALEIDO BIOSCIENCES : Announces Data from MMT Programs Accepted for Presentation at Upcomi..
AQ
2020Kaleido Biosciences Announces Data from MMT Programs Accepted for Presentation at Upcom..
GL
2020KALEIDO BIOSCIENCES : Provides Update on KB109 Clinical Data Timeline
AQ
2020Kaleido Biosciences Provides Update on KB109 Clinical Data Timeline
GL
2020KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Regulation FD Discl..
AQ
2020KALEIDO BIOSCIENCES : Appoints Daniel Menichella as President and Chief Executive Officer
AQ
2020Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer
GL
2020KALEIDO BIOSCIENCES : Announces First Patient Dosed in Clinical Study of Microbiome Metabo..
AQ
2020Kaleido Biosciences Announces First Patient Dosed in Clinical Study of Microbiome Metab..
GL
2020KALEIDO BIOSCIENCES : Thinking about buying stock in Workhorse Group, Altimmune, Endo Inte..
PR
2020KALEIDO BIOSCIENCES : to Present at Upcoming September Investor Conferences
AQ
2020Kaleido Biosciences to Present at Upcoming September Investor Conferences
GL
2020Kaleido Biosciences Announces Presentation of Data for Microbiome Metabolic Therapy KB1..
GL
2020Kaleido Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
GL
2020KALEIDO BIOSCIENCES : Reports Second Quarter 2020 Financial Results and Provides Corporate..
AQ
2020KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2020Kaleido Biosciences Initiates Controlled Clinical Study with Massachusetts General Hosp..
GL
2020KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
AQ
2020KALEIDO BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Submission of Matt..
AQ
2020KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
AQ
2020Kaleido Biosciences Announces CEO Leadership Transition
GL
2020Kaleido Biosciences Announces 2020 Annual Meeting of Stockholders to be Held as Virtual..
GL
2020KALEIDO BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events (form..
AQ
2020Kaleido Biosciences to Present During the Goldman Sachs 41st Annual Global Healthcare C..
GL
1  2Next
Upcoming event on KALEIDO BIOSCIENCES, INC.